EUVIMEDEUVIMED entdecken
Crossref

Integrating New and Emerging Treatments Into Bladder Cancer Care

Thomas W. Flaig, Charles C. Peyton

Journal of the National Comprehensive Cancer Network · 2026-05 · 24 (Supplement) · 40-43

DOI: 10.6004/jnccn.2026.5013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-05. Verfasst von Thomas W. Flaig und 1 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In both muscle-invasive bladder cancer (MIBC) and non–muscle-invasive bladder cancer (NMIBC), recent drug approvals and pivotal trial findings have changed the treatment landscape after years of stagnation. In cisplatin-eligible MIBC, perioperative durvalumab + gemcitabine and cisplatin is now a preferred regimen. For cisplatin-ineligible MIBC, perioperative treatment with enfortumab vedotin + pembrolizumab (EV+P) is preferred. Data are emerging that may move EV+P into the broader population of patients with MIBC who are eligible for cisplatin. In NMIBC, 5 therapeutics have been approved since 2018, with the newest ones boosting complete response rates to almost 50%. Pairing the standard treatment of bacillus Calmette-Guérin (BCG) with immune checkpoint inhibitors does have a biological rationale, but toxicity is concerning; those clinical trials have upheld the long-standing support for induction BCG plus maintenance. Radical cystectomy remains the preferred option for many patients with BCG-nonresponsive disease.

Zitieren

APA

Flaig, T. W., & Peyton, C. C. (2026). Integrating New and Emerging Treatments Into Bladder Cancer Care. Journal of the National Comprehensive Cancer Network, 24(Supplement), 40-43. https://doi.org/10.6004/jnccn.2026.5013

Vancouver

Flaig TW, Peyton CC. Integrating New and Emerging Treatments Into Bladder Cancer Care. Journal of the National Comprehensive Cancer Network. 2026;24(Supplement):40-43. doi:10.6004/jnccn.2026.5013

BibTeX
@article{Flaig2026,
  author = {Flaig, Thomas W. and Peyton, Charles C.},
  title = {Integrating New and Emerging Treatments Into Bladder Cancer Care},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {Supplement},
  pages = {40--43},
  doi = {10.6004/jnccn.2026.5013}
}
Kostenlos starten →